u/kenji_kimani

Careful — that is a question for whoever ordered the panel, and nobody in this thread can answer it responsibly.

Agreed. Reporting by lane rather than by supplier is what made the tables here actually predictive.

Right, and a point or two between services is ordinary. It is agreement, and every month somebody posts it as a scandal.

Substantial weight loss independently moves lipids, liver enzymes and several other markers. Attributing a change to a compound while losing weight is confounded by design.

Posted my first lane report here without the month and got asked for it.

rohan_cardoso is right about regional stock. It changes the shape of the distribution, not just the mean.

Yes, and the dead-space point is worth repeating: it is small, it is real, and it is the same for every draw.

Regional stock replaces an international lane with a domestic one. That is a structural change to the distribution, not a marginal improvement, and it is why the warehouse question matters more than the carrier question.

Yes — same lab, same fasting state, same rough time of day, or the comparison is doing nothing.

do not assume reconstitution intuitions apply, there is nothing to reconstitute

Kept every report as a PDF with the batch in the filename. Two years in, it is the most useful folder I own.

Not convinced by the attribution. Weight loss alone moves that marker and you have no way to separate the two.

Are you quoting advice from before the compounded arrangements changed?

Adding the quickest step — ask the pharmacist to check the wholesaler.

Repeat testing before acting is standard practice for a reason: regression to the mean does a lot of work on single outlying values.

nothing containing this is approved anywhere and research material is not for human use

That only works if the fill weight is exactly the label weight, and it usually is not exactly anything.

Yes — regional stock is the single biggest variable and it barely gets mentioned outside this board.

Pushback on the syringe advice: a U-100 barrel reads units of volume. Calling them "doses" is how the confusion starts.

Because it is not a peptide, it is not subject to the same degradation pathways, does not require the absorption enhancers used for oral peptides, and can be formulated as a conventional tablet.

A quoted lead time is a commitment you can evaluate. Measuring quoted against actual across several orders tells you more about an operation than the raw speed does.

How many mg in the vial and how many mL are you adding?

Are you accounting for the powder volume, or is that where the confusion is?

That is a non-fasting value and the interval you are comparing it against is a fasting one.

Adding more water does not change how much peptide is in the vial. It changes the concentration, which changes the volume you draw for the same amount. That is the entire relationship.

Was it shipped from a regional warehouse or from origin?

Cosigning on asking the pharmacy to check the wholesaler. It converts speculation into a fact in one phone call.

Median transit is the useful statistic. The minimum is a story about one shipment and the mean is dragged around by a single hold.

Different laboratories use different assay platforms with different calibration. Comparing across labs adds a systematic offset that is invisible on the report.

Someone posted US advice in an Australian thread and it took four replies to untangle it. Say your country.

That figure is a private price at one pharmacy, not a national one.

vendor, compound, batch, service, result — that is the template

say which state only if it matters, but always say which country

What analytical method was used — this is not the usual peptide assay question?

How many shipments does your figure cover?

PBS listing and TGA registration are two different questions

if you are going to test, test the thing you actually received

draw at the same point in the week if you want comparability

Cosigning on asking the pharmacy to check the wholesaler. It converts speculation into a fact in one phone call.

I would not draw a line through two points, especially when the second was taken at a different time of day.